| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3276012 | Médecine des Maladies Métaboliques | 2009 | 4 Pages |
Abstract
Do the results of the HAPO Study address all the questions on adverse outcomes associated with maternal hyperglycemia in gestational diabetes? Should they prompt new recommendations to lower threshold criteria for the diagnosis and treatment of gestational diabetes? What are the limitations of this study? A diabetologist' point of view.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
O. Vérier-Mine,